Streck Revenue and Competitors

Founded in 1971 and headquartered in Omaha, Nebraska, Streck manufactures hematology, chemistry, and immunology products for the clinical laboratory. Recognized worldwide as an innovator of hematology control products, Streck maintains 70% of the world market of hematology controls through a combination of Streck label, private label, and patent licenses. For over 30 years, Streck has been a leading developer and manufacturer of control products for the clinical laboratory. Streck developed some of the first hematology reference controls; and since that time, the company has developed many more control products for automated instruments. Streck owns more than 40 patents for clinical laboratory control products, and the company continues to invest significant resources in research and development to meet the evolving needs of clinical laboratories around the world. Clinical laboratory customers know that when a control is manufactured by Streck, they can rely on its performance. Streck's Quality Management System complies with the FDA Quality System Regulation (QSR) and is registered compliant with ISO 9001, ISO 13485, and SOR/98-282 (Canadian Medical Devices Regulations). In addition, Streck manufactures 30 products that have been declared compliant with 98/79/EC, which is the European Union's In Vitro Diagnostic Medical Devices Directive.